JP2024539150A5 - - Google Patents
Info
- Publication number
- JP2024539150A5 JP2024539150A5 JP2024523648A JP2024523648A JP2024539150A5 JP 2024539150 A5 JP2024539150 A5 JP 2024539150A5 JP 2024523648 A JP2024523648 A JP 2024523648A JP 2024523648 A JP2024523648 A JP 2024523648A JP 2024539150 A5 JP2024539150 A5 JP 2024539150A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- peptide mimetic
- subject
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163257738P | 2021-10-20 | 2021-10-20 | |
| US63/257,738 | 2021-10-20 | ||
| US202263331412P | 2022-04-15 | 2022-04-15 | |
| US63/331,412 | 2022-04-15 | ||
| PCT/US2022/045908 WO2023069255A1 (en) | 2021-10-20 | 2022-10-06 | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| USPCT/US2022/045908 | 2022-10-06 | ||
| PCT/US2022/047172 WO2023069549A1 (en) | 2021-10-20 | 2022-10-19 | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539150A JP2024539150A (ja) | 2024-10-28 |
| JP2024539150A5 true JP2024539150A5 (https=) | 2025-10-27 |
Family
ID=84329344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523648A Pending JP2024539150A (ja) | 2021-10-20 | 2022-10-19 | 眼の状態を治療、予防、阻害、改善、又はその発症を遅延させるためのペプチド模倣物を含む方法及び組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230405080A1 (https=) |
| EP (1) | EP4419123A1 (https=) |
| JP (1) | JP2024539150A (https=) |
| KR (1) | KR20240108412A (https=) |
| AU (1) | AU2022370358A1 (https=) |
| CA (1) | CA3234071A1 (https=) |
| IL (1) | IL312199A (https=) |
| WO (1) | WO2023069549A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4719404A2 (en) * | 2023-05-25 | 2026-04-08 | Stealth BioTherapeutics Inc. | Methods for addressing injection site reactions associated with the administration of bevemipretide |
| CN117982412B (zh) * | 2024-02-04 | 2024-09-17 | 济川(上海)医学科技有限公司 | 一种醋克利定眼用组合物及其药物制剂和用途 |
| US20260048096A1 (en) * | 2024-08-19 | 2026-02-19 | Stealth Biotherapeutics Inc. | Methods and compositions for preserving the retinal outer nuclear layer (onl), photoreceptors, and retinal thickness |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2521515T3 (es) * | 2008-04-04 | 2014-11-12 | Mimetogen Pharmaceuticals Inc. | Compuestos cíclicos peptidomiméticos con giro beta para tratar el ojo seco |
| AU2015264908B2 (en) * | 2008-05-09 | 2017-06-29 | Pari Pharma Gmbh | Nebuliser for Ventilation Machines and a Ventilation Machine Comprising such a Nebuliser |
| ES2964555T3 (es) * | 2009-08-24 | 2024-04-08 | Stealth Biotherapeutics Inc | Péptido para uso en la prevención o tratamiento de la degeneración macular |
| CN104244964A (zh) * | 2012-02-22 | 2014-12-24 | 康肽德生物医药技术有限公司 | 用于预防或治疗眼科病状的方法和组合物 |
| WO2015103577A1 (en) * | 2014-01-06 | 2015-07-09 | Stealth Peptides International, Inc. | Methods and compositions for preventing or treating dominant optic atrophy |
| CN115919996A (zh) * | 2015-05-01 | 2023-04-07 | 雅利斯塔制药公司 | 用于治疗眼科疾病的脂联素拟肽 |
| ES2942631T3 (es) * | 2017-12-15 | 2023-06-05 | Stealth Biotherapeutics Inc | Péptidos dirigidos a mitocondrias |
| CN112165954A (zh) * | 2018-03-23 | 2021-01-01 | 阿奇生物外科有限公司 | 用于治疗眼病的sap和拟肽 |
| AU2020316449B2 (en) * | 2019-07-24 | 2026-02-05 | Stealth Biotherapeutics Inc. | The peptidomimetic compound (R)-2-amino-N-((S)-L-(((S)-5-amino-L-(3-benzyl-1,2,4-oxadiazol-5-yl)pentyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)-l-oxopropan-2-yl)-5-guanidinopentanamide in the treatment of neurodegenerative diseases |
-
2022
- 2022-10-19 WO PCT/US2022/047172 patent/WO2023069549A1/en not_active Ceased
- 2022-10-19 CA CA3234071A patent/CA3234071A1/en active Pending
- 2022-10-19 EP EP22800952.8A patent/EP4419123A1/en active Pending
- 2022-10-19 IL IL312199A patent/IL312199A/en unknown
- 2022-10-19 JP JP2024523648A patent/JP2024539150A/ja active Pending
- 2022-10-19 AU AU2022370358A patent/AU2022370358A1/en active Pending
- 2022-10-19 KR KR1020247016730A patent/KR20240108412A/ko active Pending
-
2023
- 2023-09-01 US US18/460,346 patent/US20230405080A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024539150A5 (https=) | ||
| JP5524181B2 (ja) | 治療剤としての置換ガンマラクタム | |
| CN105899209B (zh) | 含有吡啶基氨基乙酸化合物的药物制剂 | |
| TW202602456A (zh) | 青光眼或高眼壓症之預防或治療用之組合藥劑 | |
| PH12015500025B1 (en) | Sulfonamide compound combination | |
| US12290511B2 (en) | Pharmaceutical preparation containing pyridyl aminoacetic acid compound | |
| US20220387372A1 (en) | Medicament comprising combination of sepetaprost and rho-associated coiled-coil containing protein kinase inhibitor | |
| CN118873533A (zh) | 眼用组合物 | |
| AU2019222876A1 (en) | Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC | |
| AU2004275852A1 (en) | Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders | |
| JP7829678B2 (ja) | 神経変性眼疾患を治療するためのプリドピジン及びその類似体 | |
| WO2011149012A1 (ja) | イソキノリンスルホニル誘導体を有効成分として含有する網脈絡膜変性疾患の予防または治療剤、網脈絡膜変性疾患の予防または治療方法、イソキノリンスルホニル誘導体またはその医薬的に許容される塩、ならびにその使用 | |
| CN111479567B (zh) | 包含FP激动剂和β-阻断剂的青光眼的治疗剂 | |
| JP7373904B2 (ja) | セブラノパドールの滴定 | |
| US9987368B2 (en) | Pharmaceutical composition comprising polypeptide | |
| JP2014508813A (ja) | 眼圧降下補助剤としてのｓ１ｐアンタゴニスト | |
| CN108069986B (zh) | 一种治疗角膜炎的活性药物及其制备方法 | |
| US20210106569A1 (en) | Omidenepag combination | |
| HK40102807B (en) | Combination of sepetaprost and netarsudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension | |
| HK40102807A (en) | Combination of sepetaprost and netarsudil for use in the prophylaxis or treatment of glaucoma or ocular hypertension | |
| HK40029828A (en) | Omidenepag combination | |
| HK40031074A (en) | Pharmaceutical preparation containing pyridyl aminoacetic acid compound | |
| EP0790825A1 (en) | Nk-1 receptor antagonists for the treatment of eye disorders | |
| EA050493B1 (ru) | ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ КОМБИНАЦИЮ СЕПЕТАПРОСТА И ИНГИБИТОРА Rho-АССОЦИИРОВАННОЙ ПРОТЕИНКИНАЗЫ, СОДЕРЖАЩЕЙ СУПЕРСПИРАЛЬ |